Gilead Sciences
GILD
1,888 hedge funds and large institutions have $98.5B invested in Gilead Sciences in 2024 Q4 according to their latest regulatory filings, with 291 funds opening new positions, 652 increasing their positions, 721 reducing their positions, and 93 closing their positions.
213% more first-time investments, than exits
New positions opened: 291 | Existing positions closed: 93
47% more funds holding in top 10
Funds holding in top 10: 19 → 28 (+9)
13% more capital invested
Capital invested by funds: $87.4B → $98.5B (+$11.1B)
10% more funds holding
Funds holding: 1,719 → 1,888 (+169)
1.53% more ownership
Funds ownership: 83.86% → 85.38% (+1.5%)
10% less repeat investments, than reductions
Existing positions increased: 652 | Existing positions reduced: 721
10% less call options, than puts
Call options by funds: $865M | Put options by funds: $959M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$944M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$644M |
| 3 |
Pacer Advisors
Malvern,
Pennsylvania
|
+$509M |
| 4 |
Bank of New York Mellon
New York
|
+$254M |
| 5 |
Morgan Stanley
New York
|
+$254M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
-$436M |
| 2 |
Amundi
Paris,
France
|
-$414M |
| 3 |
Capital Research Global Investors
Los Angeles,
California
|
-$347M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$257M |
| 5 |
Two Sigma Advisers
New York
|
-$200M |
GILD Hedge Fund Activity: Q4 2024 in Review
1,888 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in Gilead Sciences (GILD) for Q4 2024, worth a combined $98.5B — up 13% from $87.4B a quarter earlier.
Buyers outnumbered sellers: 291 funds opened new GILD positions and 93 closed out — a net gain of 198 holders — while 652 added to existing stakes and 721 trimmed.
The largest buyer was Bank of America, adding an estimated $944M. The largest seller was Capital World Investors, cutting an estimated $436M.
- 1,888 institutional investors held Gilead Sciences (GILD) as of Q4 2024, up from 1,719 in Q3 2024.
- Funds reported $98.5B of Gilead Sciences stock for Q4 2024, up 13% quarter-over-quarter.
- 291 funds opened new Gilead Sciences positions in Q4 2024 and 93 closed out, a net change of +198 holders.
- The largest Gilead Sciences buyer in Q4 2024 was Bank of America, an estimated $944M added.
- The largest Gilead Sciences seller in Q4 2024 was Capital World Investors, an estimated $436M sold.
Based on aggregated 13F filings for Q4 2024.